{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:05:30Z","timestamp":1785423930874,"version":"3.56.0"},"reference-count":44,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>The aim of the study was to assess the role of concentrations of interleukin-17 (IL-17), placental growth factor (PlGF) and soluble endoglin (sENG), as well as the PlGF\/sENG ratio in pregnancy complicated by pre-eclampsia (PE) and normal pregnancy. The concentrations of IL-17, PlGF and sENG were measured with the use of immunoenzymatic methods. The concentrations of IL-17 were significantly higher in PE patients when compared to control patients. In the group of patients with PE, the levels of IL-17 positively correlated with systolic blood pressure. On the other hand, IL-17 negatively correlated with neonatal birth weight. The concentrations of PLGF were significantly lower and sENG significantly higher in studied patients when compared to controls. The PlGF\/sENG ratio in the PE group was significantly lower when compared to healthy third trimester pregnant patients. In the study group, negative correlations were observed between the sENG concentrations and thrombocyte levels. The higher concentrations of IL-17 in PE could suggest its role as an inflammatory agent in the pathogenesis of the syndrome. Moreover, the negative correlation between IL-17 and a neonatal birth weight could suggest the role of the cytokine in the development of fetal growth restriction (FGR) associated with PE. It seems possible that IL-17 can be a useful marker of the risk of FGR in pregnancy complicated by PE. Furthermore, the results suggested the potential role of sENG and the PlGF\/sENG ratio in the prediction of adverse outcomes such as HELLP syndrome and DIC.<\/jats:p>","DOI":"10.3390\/ijerph20010768","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T04:17:38Z","timestamp":1672633058000},"page":"768","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Association of IL-17 and PlGF\/sENG Ratio in Pre-Eclampsia and Adverse Pregnancy Outcomes"],"prefix":"10.3390","volume":"20","author":[{"given":"Dorota","family":"Darmochwal-Kolarz","sequence":"first","affiliation":[{"name":"Medical College, University of Rzeszow, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Chara","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, 27-600 Sandomierz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"key":"ref_1","first-page":"30134","article-title":"Hypertension during pregnancy. Epidemiology, definition","volume":"4982","author":"Favel","year":"2016","journal-title":"Presse Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/1471-0528.15590","article-title":"Achieving orphan designation for placental insufficiency: Annual incidence estimations in Europe. EVERREST Consortium","volume":"126","author":"Spencer","year":"2019","journal-title":"BJOG"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Opichka, M.A., Rappelt, M.W., Gutterman, D.G., Grobe, J.L., and McIntosh, J.J. (2021). Vascular Dysfunction in Preeclampsia. Cells, 10.","DOI":"10.3390\/cells10113055"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00418-020-01892-8","article-title":"AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia","volume":"154","author":"Fantone","year":"2020","journal-title":"Histochem. Cell. Biol."},{"key":"ref_7","first-page":"823","article-title":"Cross-Talk between Oxidative Stress and Inflammation in Preeclampsia","volume":"2019","author":"Ferreira","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11906-017-0757-7","article-title":"Pathophysiology and Current Clinical Management of Preeclampsia","volume":"19","author":"Amaral","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and Regulatory T-Cell Paradigm in Pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.4049\/jimmunol.0901154","article-title":"Systemic increase in the ratio between Foxp3+ and IL-17- producing CD4+ T cells in healthy pregnancy but not in preeclampsia","volume":"183","author":"Peek","year":"2009","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jri.2012.01.006","article-title":"The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia","volume":"93","author":"Tabarkiewicz","year":"2012","journal-title":"J. Reprod. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jri.2009.09.005","article-title":"A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour","volume":"84","author":"Ito","year":"2010","journal-title":"J. Reprod. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0897.2010.00812.x","article-title":"Accumulation of IL-17-positive cells in decidua of inevitable abortion cases","volume":"64","author":"Nakashima","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000334458","article-title":"Antiangiogenic-Induced Hypertension: The Molecular Basis of Signaling Network","volume":"73","author":"Nagai","year":"2012","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tjog.2016.06.019","article-title":"Molecular regulation and role of angiogenesis in preeclampsia","volume":"56","author":"Rizov","year":"2017","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, Challenges, and Perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0032-1328601","article-title":"Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)\/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria","volume":"73","author":"Lehnen","year":"2013","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","article-title":"Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: Novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders","volume":"1","author":"Autiero","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0003319720903586","article-title":"Novel Biomarkers for Evaluation of Endothelial Dysfunction","volume":"71","author":"Leite","year":"2020","journal-title":"Angiology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Schoonderwoerd, M.J.A., Goumans, M.T.H., and Hawinkels, L.J.A.C. (2020). Endoglin: Beyond the Endothelium. Biomolecules, 10.","DOI":"10.3390\/biom10020289"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00018-017-2694-7","article-title":"Humane endoglin as a potential new partner involved in platelet-endothelium interactions","volume":"75","author":"Rossi","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10456-016-9495-8","article-title":"Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury","volume":"19","author":"Blanco","year":"2016","journal-title":"Angiogenesis"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Aristorena, M., Gallardo-Vara, E., Vicen, M., Casas-Engel, M.D.L., Ojeda-Fernandez, L., Nieto, C., Blanco, F.J., Valbuena-Diez, A.C., Botella, L.M., and Nachtigal, P. (2019). MMP-12, secreted by pro-inflammatory macrophages, targets endoglin in human macrophages and endothelial cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123107"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2020). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet. Gynecol., 135, e237\u2013e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clim.2008.07.032","article-title":"Distinct subsets of regulatory T cells during pregnancy: Is the imbalance of these subsets involved in the pathogenesis of preeclampsia?","volume":"129","author":"Steinborn","year":"2008","journal-title":"Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2007.03397.x","article-title":"Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia","volume":"149","author":"Sasaki","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0897.2010.00893.x","article-title":"IL-17 increased in the third trimester in healthy women with term labor","volume":"65","author":"Atahualpa","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R353","DOI":"10.1152\/ajpregu.00051.2012","article-title":"IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy","volume":"303","author":"Dhillion","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: Risk factors and outcomes associated with early-versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"174.e1","DOI":"10.1016\/j.ajog.2007.03.058","article-title":"Soluble endoglin as a second-trimester marker for preeclampsia","volume":"197","author":"Robinson","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3889\/oamjms.2019.154","article-title":"The Role of Placental Growth Factor, Soluble Endoglin, and Uterine Artery Diastolic Notch to Predict the Early Onset of Preeclampsia","volume":"7","author":"Hariman","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The Use of Angiogenic Biomarkers in Maternal Blood to Identify Which SGA Fetuses Will Require a Preterm Delivery and Mothers Who Will Develop Pre-Eclampsia","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.13348","article-title":"Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes","volume":"74","year":"2019","journal-title":"Hypertension"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.326.7393.791","article-title":"Risk of subsequent thromboembolism for patients with pre-eclampsia","volume":"326","author":"Mamdani","year":"2003","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4314\/ahs.v18i3.15","article-title":"Fibrinolytic Proteins of Normal Pregnancy and Pre-Eclamptic Patients in North West Nigeria","volume":"18","author":"Olawumi","year":"2018","journal-title":"Afr. Health Sci."},{"key":"ref_42","first-page":"140","article-title":"Longitudinal Evaluation of Markers of Hemostasis in Pregnancy","volume":"115","author":"Hammerova","year":"2014","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2009.03344.x","article-title":"Pregnancy Outcome and Fibrinolytic, Endothelial and Coagulation Markers in Women Undergoing Uterine Artery Doppler Screening at 23 Weeks","volume":"7","author":"Hunt","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.prp.2017.10.021","article-title":"Angiogenic and Antiangiogenic Factors in Preeclampsia","volume":"214","author":"Helmo","year":"2018","journal-title":"Pathol. Res. Pract."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/20\/1\/768\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:49:11Z","timestamp":1760147351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/20\/1\/768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijerph20010768"],"URL":"https:\/\/doi.org\/10.3390\/ijerph20010768","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]}}}